Post-Stroke Spasticity Treatment: A Retrospective Cohort Study From Alberta, Canada
We found evidence of gaps in provision of spasticity management in persons with PSS including overuse of systemic oral baclofen (that has common adverse side effects and lacks evidence of effectiveness in PSS) and potential underuse of focal botulinum toxin injections. Further investigation and strategies should be pursued to improve alignment of PSS treatment with guideline recommendations that in turn will support better outcomes for those with PSS.
Authors
- Jaime C. Yu (ORCID: https://orcid.org/0000-0003-3486-5515)
- Lalith Satkunam (ORCID: https://orcid.org/0000-0002-4736-2733)
- Scott Klarenbach (ORCID: https://orcid.org/0000-0002-8611-1056)
- Lawrence Richer
- Sean Peter Dukelow (ORCID: https://orcid.org/0000-0002-0609-981X)
- Khanh Vu (ORCID: https://orcid.org/0000-0002-4319-1922)
- Tyler Williamson (ORCID: https://orcid.org/0000-0001-5029-2345)
- Huong Luu
- Stephen McNeil
- Karen J. B. Martins (ORCID: https://orcid.org/0000-0002-3400-7214)
- Phuong Uyen Nguyen
Institutions
- University of Alberta (CA)
- University of Calgary (CA)
- Alberta Children's Hospital (CA)
- Glenrose Rehabilitation Hospital (CA)
- Libin Cardiovascular Institute of Alberta (CA)
Publication Details
- Journal
- Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques
- Published
- 2024-11-11
- DOI
- https://doi.org/10.1017/cjn.2024.342
- Citations
- 2
- Primary Topic
- Botulinum Toxin and Related Neurological Disorders
- Type
- article
- Field-Weighted Citation Impact
- 0.74